Progress in tuberculosis diagnosis and laboratory services in the Western Pacific Region: a situational analysis of seven high tuberculosis burden countries
Authors:
- Kyung Hyun OhKOKyung Hyun Oh
- Pheng Sok HengPHPheng Sok Heng
- Narith RathaNRNarith Ratha
Open Access
- 18 May 2026
- journal article
- review article
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 54 (1)
Abstract
Background: Timely, accurate tuberculosis (TB) diagnostics and strong laboratory networks are critical for providing high-quality TB care. In the Western Pacific Region, available resources, TB burdens, and access to TB testing vary dramatically between countries. To understand the current regional situation, we described TB diagnostic test availability and laboratory services in seven countries with high TB burdens in the Western Pacific Region: Main text: In 2024, World Health Organization’s (WHO) Western Pacific Regional Office conducted an assessment of TB diagnostic test availability and laboratory services in seven countries with high TB burdens: Cambodia, China, Lao People’s Democratic Republic, Mongolia, Philippines, Papua New Guinea, and Viet Nam. Standardised surveys were sent to members of country national tuberculosis programmes, and follow-up interviews were conducted. An in-person workshop was attended where preliminary findings were presented and updated, if necessary. The exercise revealed a high uptake of WHO-endorsed rapid molecular tests for TB detection, although the use of smear microscopy persists in most countries’ remote areas. Regarding drug susceptibility testing, both molecular and phenotypic methods are employed. Testing for first-line TB drug resistance is generally available, but currently, testing capacity for new and re-purposed drugs remains limited. Most countries provide TB testing at district-level facilities in conjunction with well-established specimen transport networks, with laboratories utilising a mix of paper and electronic databases. Comprehensive TB and drug-resistance testing at peripheral settings remains a rarity. Conclusions: The Western Pacific Region has invested significantly in TB testing and laboratory services. To ensure everyone in the region has access to TB diagnostics, these efforts must be maintained.Keywords
Funding Information
- Canadian Institutes of Health Research (472823)
This publication has 16 references indexed in Scilit:
- US aid cuts are an opportunity to reimagine global healthNature Medicine, 2025
- ‘It is chaos’: US funding freezes are endangering global healthNature, 2025
- Global wage report 2024-252024
- Covid-19’s Devastating Effect on Tuberculosis Care — A Path to RecoveryNew England Journal of Medicine, 2022
- The Lancet Commission on diagnostics: transforming access to diagnosticsThe Lancet, 2021
- The impact of COVID-19 on TB: a review of the dataThe International Journal of Tuberculosis and Lung Disease, 2021
- Learning from COVID-19 to reimagine tuberculosis diagnosisThe Lancet Microbe, 2021
- Epidemiology of tuberculosis in the Western Pacific Region: Progress towards the 2020 milestones of the End TB StrategyWestern Pacific Surveillance and Response Journal, 2020
- Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic ReviewJournal of Medical Internet Research, 2019
- Electronic Patient Portals: Evidence on Health Outcomes, Satisfaction, Efficiency, and AttitudesAnnals of Internal Medicine, 2013